Plunkett Research Online: Kancera

KANCERA (KNCQF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kancera AB focuses on development and sale of drug candidates that have potential to cure or to stop the progression of cancer. Its activities are divided into Pharmaceutical Development and Industrial Research and Development......



Kancera
Ticker: KNCQF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 850126080
Fax:
Address: Karolinska Institutet Science Park
Banvaktsvägen 22
Solna, 171 48 Sweden

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription

Kancera AB focuses on development and sale of drug candidates that have potential to cure or to stop the progression of cancer. Its activities are divided into Pharmaceutical Development and Industrial Research and Development......See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: